Other Pharmaceuticals - North Macedonia

  • North Macedonia
  • The revenue in the Other Pharmaceuticals market in North Macedonia is estimated to reach US$34.25m by 2024.
  • It is anticipated to experience an annual growth rate (CAGR 2024-2029) of 4.66%, leading to a market volume of US$43.00m by 2029.
  • In terms of global comparison, United States is expected to generate the highest revenue of US$260.50bn in 2024.
  • North Macedonia is experiencing a surge in demand for other pharmaceuticals due to an increasing emphasis on healthcare and a growing aging population.

Key regions: China, Europe, Australia, United States, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Pharmaceuticals market in North Macedonia has been showing interesting developments in recent years.

Customer preferences:
Customers in North Macedonia have been showing an increasing interest in alternative and natural medicines. This has led to a growing demand for Other Pharmaceuticals, which includes products such as vitamins, minerals, and herbal supplements. Additionally, the aging population in North Macedonia has also contributed to the growth of this market, as older individuals tend to use more healthcare products.

Trends in the market:
One of the main trends in the Other Pharmaceuticals market in North Macedonia is the increasing availability of these products in pharmacies and drugstores. This has made it easier for customers to access these products and has contributed to the growth of the market. Additionally, there has been a growing trend towards online shopping, which has also impacted the Other Pharmaceuticals market. Many customers now prefer to purchase these products online, which has led to the emergence of several e-commerce platforms that specialize in healthcare products.

Local special circumstances:
North Macedonia has a relatively small market for healthcare products, which has led to a high level of competition among suppliers. This has resulted in a focus on product innovation and differentiation, as companies try to stand out in a crowded market. Additionally, the regulatory environment for healthcare products in North Macedonia is relatively strict, which has led to a focus on quality and safety among suppliers.

Underlying macroeconomic factors:
The healthcare sector in North Macedonia has been growing in recent years, which has contributed to the growth of the Other Pharmaceuticals market. Additionally, the country has been experiencing economic growth, which has led to an increase in disposable income among consumers. This has made it easier for customers to purchase healthcare products, including Other Pharmaceuticals. Finally, the government in North Macedonia has been investing in healthcare infrastructure, which has helped to improve access to healthcare products and services across the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)